MRK
Merck & Co., Inc. · Healthcare
Chair, CEO and President Robert M Davis sold $5.6M of Merck & Co., Inc.
Sold$5,599,327
$118.05Price
47,434Shares
−10%Stake
What MRK did after the filing
- The stock from Mon, Feb 9 open, $121.41
- −4.2%
- S&P 500, same days
- −5.3%
Measured over 30 trading days, to the Mar 24 close.
Traded Wed, Feb 4. Filed Fri, Feb 6, 4:05 PM ET, after the close. Returns use the Feb 9 open and the Mar 24 close. Not investment advice.